The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition

V Michaud, T Bar-Magen, J Turgeon, D Flockhart… - Pharmacological …, 2012 - ASPET
Significant intra-and interindividual variability has been observed in response to use of
pharmacological agents in treatment of HIV infection. Treatment of HIV infection is limited by …

[HTML][HTML] Human immunodeficiency virus infection and the liver

M Crane, D Iser, SR Lewin - World journal of hepatology, 2012 - ncbi.nlm.nih.gov
Liver disease in human immunodeficiency virus (HIV)-infected individuals encompasses the
spectrum from abnormal liver function tests, liver decompensation, with and without …

Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons

L Ryom, JD Lundgren, S De Wit, H Kovari, P Reiss… - Aids, 2016 - journals.lww.com
Objectives: Although several antiretroviral drugs, including the d-drugs stavudine (d4T) and
didanosine (ddI), may cause biomarker-defined hepatotoxicity, their association with …

[HTML][HTML] Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma

W Mattes, K Davis, E Fabian, J Greenhaw, M Herold… - Toxicology letters, 2014 - Elsevier
While conventional parameters used to detect hepatotoxicity in drug safety assessment
studies are generally informative, the need remains for parameters that can detect the …

Drug-induced liver injury: a summary of recent advances

JG Stine, JH Lewis - Expert opinion on drug metabolism & …, 2011 - Taylor & Francis
Introduction: The knowledge base of drug-induced liver injury (DILI) continues to grow each
year as additional drugs are identified as hepatotoxins. There is still a need to improve our …

Animal models of idiosyncratic drug reactions

W Ng, ARM Lobach, X Zhu, X Chen, F Liu… - Advances in …, 2012 - Elsevier
If we could predict and prevent idiosyncratic drug reactions (IDRs) it would have a profound
effect on drug development and therapy. Given our present lack of mechanistic …

Cohort profile: the Khayelitsha antiretroviral programme, Cape town, South Africa

K Stinson, E Goemaere, D Coetzee… - International Journal …, 2017 - academic.oup.com
Khayelitsha is Cape Town's largest township, approximately 35km from the city centre. It was
originally developed as a dormitory town to house the increasing influx of African migrant …

Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia

W Mulu, B Gidey, A Chernet, G Alem, B Abera - Ethiopian journal of health …, 2013 - ajol.info
Background: In Human Immunodeficiency Virus (HIV) infected patients on antiretroviral
treatment (ART), hepatotoxicity is life threatening. Its outcome may lead to liver failure and …

The impact of illustrated side effect information on understanding and sustained retention of antiretroviral side effect knowledge

SH Browne, K Barford, T Ramela, R Dowse - Research in Social and …, 2019 - Elsevier
Background Prompt management of side effects is critical to supporting adherence to
antiretroviral (ARV) medication. Objective This study examines the impact of presenting side …

Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti …

H Kovari, CA Sabin, B Ledergerber… - Clinical infectious …, 2013 - academic.oup.com
Background. Liver diseases are the leading causes of death in human immunodeficiency
virus (HIV)–positive persons since the widespread use of combination antiretroviral …